Magnesium and Riboflavin Treatment for Post-Concussion Headache
ConditionConcussion, Intermediate
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-40
SponsorUniversity of Virginia
About this trial
This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person.
Eligibility criteria
Qualifiers
Seen at University of Virginia Student Health and Wellness Center or Emergency Department for Initial Visit for Concussion;
Less than 3 days have elapsed since their injury;
Able to swallow capsules
Disqualifiers
Concussion complicated by cranial bleed, skull fracture, additional severe injury;
Kidney disfunction or failure;
Significant gastro-intestinal dysfunction;
Varsity Athlete;
Trial design
Treatments tested in this trial
- magnesium and riboflavin supplement
Treatment groups
108 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov